Edifice program: analysis of screening exam practices for cancer in France

被引:6
|
作者
Blay, J. -Y. [1 ]
Eisinger, F. [2 ,3 ]
Rixe, O. [4 ]
Calazel-Benque, A. [5 ]
Morere, J. -F. [6 ]
Cals, L. [7 ]
Coscas, Y. [8 ]
Dolbeault, S. [9 ]
Namer, M. [10 ]
Serin, D. [11 ]
Roussl, C. [12 ]
Pivot, X. [13 ]
机构
[1] Ctr Leon Berard, INSERM, UJOMM HEH & Conticanet FP6 018806, U590, F-69373 Lyon, France
[2] Inst J Paoli I Calmettes, Dept Oncogenet Screening & Prevent, F-13009 Marseille, France
[3] INSERM, U599, F-13009 Marseille, France
[4] Hop La Pitie Salpetriere, F-75013 Paris, France
[5] Capio Clin Parc, F-31400 Toulouse, France
[6] Hop Avicenne, F-93000 Bobigny, France
[7] Hop Font Pre, F-83100 Toulon, France
[8] Clin Porte de St Cloud, F-92100 Boulogne, France
[9] Inst Curie, Psychooncol Unit, F-75020 Paris, France
[10] Ctr Azureen Cancerol, F-06250 Mougins, France
[11] Inst St Catherine, F-84000 Avignon, France
[12] Lab Roche, F-92000 Neuilly, France
[13] CHU Besancon, F-25030 Besancon, France
关键词
rectum; screening exam; cancer; breast; colon; prostate;
D O I
10.1684/bdc.2008.0747
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction. The practices of screening and the parameters influencing these practices are not well known in France. The objectives of the Edifice study were to analyze a large cohort of patients and doctors in order to further characterize these parameters, Patients and methods. The study was performed by the Institute TNS Healthcare-SOFRES, and included 2 parallel studies: 1) on 1 609 healthy persons representative of the global French population and aged 40 to 75 years (N = 1 5 09), with an over representation of patients aged 50 to 74 years living in the 22 pilot French departments pilots; 2) on 600 generalist practitioners. Data were collected and analyzed by the expert panel... Results. Ninety-three, 25, 36 and 6% of the patients in the general population declared to have performed at least one a screening exam for breast, colon, prostate, and lung carcinoma respectively.. Seventy, 20, 60 and 4% of GP declare to propose systematically to a 40-75-year-old patient a screening test for breast, colon, prostate, or lung cancer, For breast cancer screening the adhesion of the GP is independent of the date of implementation of a general screening in their own regions., while for colorectal screening, 34 and 20% of the patients living in the pilot versus other departments were screened. Overall, prostate cancer screening is recommended by the GP panel for 77.1% of patients aged 50 to 75 years. Conclusions. This study shows a good adhesion of screening procedures for GP and patients, shows that screening is improved by general screening policy in colorectal cancer, but that prostate cancer screening practices exceed what is recommended according to evidence based medicine.
引用
收藏
页码:1067 / 1073
页数:7
相关论文
共 50 条
  • [1] Cancer screening in France: 10 years of analysis of behaviours by the EDIFICE surveys
    Eisinger, Francois
    Pivot, Xavier
    Greillier, Laurent
    Couraud, Sebastien
    Cortot, Alexis B.
    Touboul, Chantal
    Lhomel, Christine
    Blay, Jean-Yves
    Morere, Jean-Francois
    Viguier, Jerome
    BULLETIN DU CANCER, 2017, 104 (03) : 258 - 266
  • [2] Prostate cancer Screening in France: Results of the EDIFICE study
    Rixe, Olivier
    Blay, Jean-Yves
    Calazel-Benque, Anne
    Cals, Laurent
    Coscas, Yvan
    Pivot, Xavier
    Eisinger, Francois
    Dolbeault, Sylvie
    Roussel, Claire
    Morere, Jean-Francois
    ANNALS OF ONCOLOGY, 2006, 17 : 276 - 276
  • [3] Cancer screening in France: third edition of the EDIFICE survey
    Viguier, Jerome
    Morere, Jean-Francois
    Touboul, Chantal
    Coscas, Yvan
    Blay, Jean-Yves
    Lhomel, Christine
    Pivot, Xavier
    Eisinger, Francois
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2015, 24 : S68 - S72
  • [4] Prostate cancer screening in France: Results from the EDIFICE surveys
    Morere, J. -F.
    Touboul, C.
    Lhonnel, C.
    Roupret, M.
    PROGRES EN UROLOGIE, 2020, 30 (06): : 332 - 338
  • [5] Breast cancer screening in France: results of the EDIFICE survey.
    Pivot, X.
    Rixe, O.
    Morere, J-F
    Namer, M.
    Serin, D.
    Dolbeault, S.
    Blay, J-Y
    Eisinger, F.
    Roussel, C.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S130 - S130
  • [6] Cancer screening tests in France: First results of the EDIFICE study.
    Pivot, Xavier
    Morere, Jean-Franccois
    Namer, Moise
    Rixe, Olivier
    Cals, Laurent
    Serin, Daniel
    Eisinger, Francois
    Dolbeault, Sylvie
    Roussel, Claire
    Blay, Jean-Yves
    ANNALS OF ONCOLOGY, 2006, 17 : 275 - 275
  • [7] Cancer screening tests in France: First results of EDIFICE study.
    Pivot, X.
    Serin, D.
    Coscas, Y.
    Eisinger, F.
    Rixe, O.
    Roussel, C.
    Morere, J.
    Blay, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 323S - 323S
  • [8] Screening for colorectal cancer in France: Third edition of the EDIFICE survey.
    Viguier, Jerome
    Morere, Jean F.
    Pivot, Xavier B.
    Coscas, Yvan
    Blay, Jean-Yves
    Roussel, Claire
    Eisinger, Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [9] Factors associated with compliance to cervical cancer screening in France: The EDIFICE 6 survey
    Rouge, Thibault de la Motte
    Touboul, Chantal
    Lhomel, Christine
    Roupret, Morgan
    Morere, Jean-Francois
    GYNECOLOGIC ONCOLOGY, 2021, 160 (01) : 112 - 117
  • [10] Cancer screening in France: 3rd edition of the EDIFICE survey.
    Viguier, Jerome
    Eisinger, Francois
    Coscas, Yvan
    Morere, Jean F.
    Blay, Jean-Yves
    Roussel, Claire
    Pivot, Xavier B.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)